grant
National Institutes of Health
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Source: grants.gov CFDA: Status: posted Lifecycle: modified
Eligibility
See opportunity for details